François Lokiec

François Lokiec

Institut Curie - Paris / France
Others
AD Scientific Index ID: 4475398
Curie Institute
person_outline François Lokiec's MOST POPULAR ARTICLES
1-) Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyC Berthon, E Raffoux, X Thomas, N Vey, C Gomez-Roca, K Yee, ...The Lancet Haematology 3 (4), e186-e195, 20163512016
2-) Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 studyS Amorim, A Stathis, M Gleeson, S Iyengar, V Magarotto, X Leleu, ...The Lancet Haematology 3 (4), e196-e204, 20163452016
3-) Severe CPT-11 toxicity in patients with Gilbert\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s syndrome: two case reportsE Wasserman, A Myara, F Lokiec, F Goldwasser, F Trivin, M Mahjoubi, ...Annals of Oncology 8 (10), 1049-1051, 19972491997
4-) Population pharmacokinetics of total and unbound plasma cisplatin in adult patientsS Urien, F LokiecBritish journal of clinical pharmacology 57 (6), 756-763, 20041792004
5-) Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokineticsE Wasserman, C Cuvier, F Lokiec, F Goldwasser, S Kalla, ...Journal of clinical oncology 17 (6), 1751-1751, 19991781999